Expression and immunolocalisation of neutral endopeptidase in prostate cancer.

Expression and immunolocalisation of neutral endopeptidase in prostate cancer.

BACKGROUND: Neutral Endopeptidase (NEP) is a cell surface enzyme that cleaves and inactivates neuropeptides. When present on androgen-dependent prostate cancer (PC) cells, NEP inactivates growth stimulatory neuropeptides. After androgen ablation NEP expression decreases and neuropeptides can enhanc...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Albrecht, M, Mittler, A, Wilhelm, B, Lundwall, A, Lilja, H, Aumüller, G, Bjartell, A
Format:	Journal article
Język:	English
Wydane:	2003

Podobne zapisy

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
od: Cao, Y, i wsp.
Wydane: (2002)

A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue.
od: Valtonen-André, C, i wsp.
Wydane: (2007)

Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
od: Olsson, A, i wsp.
Wydane: (2005)

Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues.
od: Cao, Y, i wsp.
Wydane: (2003)

Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues.
od: Bjartell, A, i wsp.
Wydane: (2000)

CD1 antibody immunolocalisation in Langerhans' cell histiocytosis.
od: Pritchard, K, i wsp.
Wydane: (1993)

Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
od: Bjartell, A, i wsp.
Wydane: (2006)

Tumor markers in prostate cancer I: blood-based markers.
od: Shariat, S, i wsp.
Wydane: (2011)

Quantitative PSA RT-PCR for preoperative staging of prostate cancer.
od: Kurek, R, i wsp.
Wydane: (2003)

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
od: Dahlman, A, i wsp.
Wydane: (2010)

Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen.
od: Olsson, A, i wsp.
Wydane: (2004)

Screening for prostate cancer.
od: Carlsson, S, i wsp.
Wydane: (2012)

Immunolocalisation of sodium channel NaG in the intact and injured human peripheral nervous system.
od: Coward, K, i wsp.
Wydane: (2001)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
od: Vickers, A, i wsp.
Wydane: (2010)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
od: Vickers, A, i wsp.
Wydane: (2010)

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
od: Ulmert, D, i wsp.
Wydane: (2009)

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
od: Lilja, H, i wsp.
Wydane: (2008)

Screening for prostate cancer: To the editor
od: Carlsson, S, i wsp.
Wydane: (2012)

Turning an asparaginyl endopeptidase into a peptide ligase
od: Hemu, Xinya, i wsp.
Wydane: (2021)

Urological cancer: Time for another rethink on prostate cancer screening.
od: Vickers, A, i wsp.
Wydane: (2012)

Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
od: Botchorishvili, G, i wsp.
Wydane: (2009)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
od: Haese, A, i wsp.
Wydane: (2004)

Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
od: Siivola, P, i wsp.
Wydane: (2000)

IgG endopeptidase in highly sensitized patients undergoing transplantation
od: Jordan, S, i wsp.
Wydane: (2017)

Prostate cancer: estimating the benefits of PSA screening.
od: Vickers, A, i wsp.
Wydane: (2009)

miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
od: Hagman, Z, i wsp.
Wydane: (2010)

Circulating biomarkers for prostate cancer.
od: Steuber, T, i wsp.
Wydane: (2007)

Screening for prostate cancer: an update.
od: Shariat, S, i wsp.
Wydane: (2008)

Screening for prostate cancer: early detection or overdetection?
od: Vickers, A, i wsp.
Wydane: (2012)

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
od: Lilja, H, i wsp.
Wydane: (2011)

Five genetic variants associated with prostate cancer.
od: Vickers, A, i wsp.
Wydane: (2008)

THE P-MARK BIOBANK: A EUROPEAN MULTICENTER BIOREPOSITORY FOR PROSTATE CANCER RESEARCH
od: Marsden, G, i wsp.
Wydane: (2009)

An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6.
od: Steiner, H, i wsp.
Wydane: (2004)

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
od: Bangma, C, i wsp.
Wydane: (2010)

A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein.
od: Clauss, A, i wsp.
Wydane: (2002)

A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein
od: Clauss, A, i wsp.
Wydane: (2002)

Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring (Corrigendum) (Nature Reviews Cancer (2008) 8, (268-278))
od: Lilja, H, i wsp.
Wydane: (2008)

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
od: Klein, R, i wsp.
Wydane: (2012)

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
od: Vickers, A, i wsp.
Wydane: (2011)

Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
od: Klein, R, i wsp.
Wydane: (2010)